STAT5 Activity in Pancreatic β-Cells Influences the Severity of Diabetes in Animal Models of Type 1 and 2 Diabetes
暂无分享,去创建一个
Ying-Chu Lee | J. Nielsen | A. Møldrup | M. Jackerott | P. Thams | Malene Jackerott | Annette Møldrup | Peter Thams | Elisabeth D Galsgaard | Jakob Knudsen | Ying C Lee | Jens Høiriis Nielsen | J. Knudsen | E. Galsgaard | Ying‐Chu Lee | J. Nielsen
[1] B. Friedrichsen,et al. Stimulation of pancreatic β-cell replication by incretins involves transcriptional induction of cyclin D1 via multiple signalling pathways , 2006 .
[2] X. Niu,et al. Inhibition of preproinsulin gene expression by leptin induction of suppressor of cytokine signaling 3 in pancreatic beta-cells. , 2005, Diabetes.
[3] Ying-Chu Lee,et al. STAT5 activation by human GH protects insulin-producing cells against interleukin-1β, interferon-γ and tumour necrosis factor-α-induced apoptosis independent of nitric oxide production , 2005 .
[4] S. G. Rønn,et al. Regulation of pancreatic β-cell mass and proliferation by SOCS-3 , 2005 .
[5] J. Kushner,et al. Cyclins D2 and D1 Are Essential for Postnatal Pancreatic β-Cell Growth , 2005, Molecular and Cellular Biology.
[6] S. G. Rønn,et al. Regulation of pancreatic beta-cell mass and proliferation by SOCS-3. , 2005, Journal of molecular endocrinology.
[7] J. Kushner,et al. Cyclins D2 and D1 are essential for postnatal pancreatic beta-cell growth. , 2005, Molecular and cellular biology.
[8] R. Vasavada,et al. Characterization of mice doubly transgenic for parathyroid hormone-related protein and murine placental lactogen: a novel role for placental lactogen in pancreatic beta-cell survival. , 2004, Diabetes.
[9] Senta Georgia,et al. β cell replication is the primary mechanism for maintaining postnatal β cell mass , 2004 .
[10] M. Lipsett,et al. Disruption of growth hormone receptor gene causes diminished pancreatic islet size and increased insulin sensitivity in mice. , 2004, American journal of physiology. Endocrinology and metabolism.
[11] R. Sorenson,et al. Distinctive roles for prolactin and growth hormone in the activation of signal transducer and activator of transcription 5 in pancreatic islets of langerhans. , 2004, Endocrinology.
[12] S. Akira,et al. Insulin secretory defects and impaired islet architecture in pancreatic beta-cell-specific STAT3 knockout mice. , 2004, Biochemical and biophysical research communications.
[13] J. Richardson,et al. Essential Role of STAT3 in Body Weight and Glucose Homeostasis , 2004, Molecular and Cellular Biology.
[14] Senta Georgia,et al. Beta cell replication is the primary mechanism for maintaining postnatal beta cell mass. , 2004, The Journal of clinical investigation.
[15] H. Sone,et al. Pancreatic beta cell senescence contributes to the pathogenesis of type 2 diabetes in high-fat diet-induced diabetic mice , 2004, Diabetologia.
[16] R. Paschke,et al. Regulation of adipocytokines and insulin resistance , 2003, Diabetologia.
[17] B. Friedrichsen,et al. Signal Transducer and Activator of Transcription 5 Activation Is Sufficient to Drive Transcriptional Induction of Cyclin D2 Gene and Proliferation of Rat Pancreatic β-Cells , 2003 .
[18] Robert A. Rizza,et al. β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes , 2003, Diabetes.
[19] J. Morisset. IN PANCREATIC GROWTH AND REGENERATION , 2003 .
[20] B. Friedrichsen,et al. Signal transducer and activator of transcription 5 activation is sufficient to drive transcriptional induction of cyclin D2 gene and proliferation of rat pancreatic beta-cells. , 2003, Molecular endocrinology.
[21] C. Rhodes,et al. Pancreatic β-cell growth and survival – a role in obesity-linked type 2 diabetes? , 2002 .
[22] P. Kelly,et al. Printed in U.S.A. Copyright © 2002 by The Endocrine Society Targeted Deletion of the PRL Receptor: Effects on Islet Development, Insulin Production, and Glucose Tolerance , 2022 .
[23] C. Rhodes,et al. Pancreatic beta-cell growth and survival--a role in obesity-linked type 2 diabetes? , 2002, Trends in molecular medicine.
[24] Y. Oka,et al. Leptin increases the viability of isolated rat pancreatic islets by suppressing apoptosis. , 2001, Endocrinology.
[25] F. Pociot,et al. Suppressor of cytokine signaling 3 (SOCS-3) protects β-cells against interleukin-1β- and interferon-γ-mediated toxicity , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[26] T. Zhu,et al. Signal transduction via the growth hormone receptor. , 2001, Cellular signalling.
[27] M. Tadayyon,et al. Fatty acids inhibit leptin signalling in BRIN-BD11 insulinoma cells. , 2001, Journal of molecular endocrinology.
[28] B. Friedrichsen,et al. Regulation of beta-cell mass by hormones and growth factors. , 2001, Diabetes.
[29] F. Pociot,et al. Suppressor of cytokine signaling 3 (SOCS-3) protects beta -cells against interleukin-1beta - and interferon-gamma -mediated toxicity. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[30] B. Friedrichsen,et al. Growth hormone- and prolactin-induced proliferation of insulinoma cells, INS-1, depends on activation of STAT5 (signal transducer and activator of transcription 5). , 2001, Molecular endocrinology.
[31] B. Friedrichsen,et al. Regulation of-Cell Mass by Hormones and Growth Factors , 2001 .
[32] V. Emilsson,et al. Fetal pancreatic islets express functional leptin receptors and leptin stimulates proliferation of fetal islet cells , 2000, International Journal of Obesity.
[33] F. Talamantes,et al. Targeted Expression of Placental Lactogen in the Beta Cells of Transgenic Mice Results in Beta Cell Proliferation, Islet Mass Augmentation, and Hypoglycemia* , 2000, The Journal of Biological Chemistry.
[34] J. Habener,et al. The adipoinsular axis: effects of leptin on pancreatic β-cells , 2000 .
[35] J. Habener,et al. The adipoinsular axis: effects of leptin on pancreatic beta-cells. , 2000, American journal of physiology. Endocrinology and metabolism.
[36] S. Sandler,et al. Prolactin protects against diabetes induced by multiple low doses of streptozotocin in mice. , 1999, The Journal of endocrinology.
[37] H. Lodish,et al. Fetal Anemia and Apoptosis of Red Cell Progenitors in Stat5a−/−5b−/− Mice A Direct Role for Stat5 in Bcl-XL Induction , 1999, Cell.
[38] F. Cavagnini,et al. Growth hormone in obesity , 1999, International Journal of Obesity.
[39] C. Ricordi,et al. Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1999 by The Endocrine Society Leptin Suppression of Insulin Secretion and Gene Expression in Human Pancreatic Islets: Implications for the Development of Adipogenic Diabetes Me , 2022 .
[40] J. Beavo,et al. Leptin inhibits insulin secretion by activation of phosphodiesterase 3B. , 1998, The Journal of clinical investigation.
[41] C. Newgard,et al. Protection against lipoapoptosis of beta cells through leptin-dependent maintenance of Bcl-2 expression. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[42] M. McMahon,et al. Identification and Characterization of a Constitutively Active STAT5 Mutant That Promotes Cell Proliferation , 2022 .
[43] P. Kelly,et al. Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. , 1998, Endocrine reviews.
[44] G. Reach,et al. Inhibition of insulin secretion by leptin in normal rodent islets of Langerhans. , 1998, Endocrinology.
[45] Y. Oka,et al. Leptin induces proliferation of pancreatic beta cell line MIN6 through activation of mitogen-activated protein kinase. , 1997, Biochemical and biophysical research communications.
[46] V. Emilsson,et al. Expression of the Functional Leptin Receptor mRNA in Pancreatic Islets and Direct Inhibitory Action of Leptin on Insulin Secretion , 1997, Diabetes.
[47] N. Sarvetnick. Pancreatic growth and regeneration , 1997 .
[48] B. Groner,et al. Deletion of the carboxyl-terminal transactivation domain of MGF-Stat5 results in sustained DNA binding and a dominant negative phenotype , 1996, Molecular and cellular biology.
[49] P. Serup,et al. Identification of a growth hormone-responsive STAT5-binding element in the rat insulin 1 gene. , 1996, Molecular endocrinology.
[50] D. Allan,et al. BETA‐CELL APOPTOSIS IS RESPONSIBLE FOR THE DEVELOPMENT OF IDDM IN THE MULTIPLE LOW‐DOSE STREPTOZOTOCIN MODEL , 1996, The Journal of pathology.
[51] B. Groner,et al. Cloning and expression of Stat5 and an additional homologue (Stat5b) involved in prolactin signal transduction in mouse mammary tissue. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[52] M. Feinglos,et al. Impaired second phase insulin response of diabetes-prone C57BL/6J mouse islets , 1995, Physiology & Behavior.
[53] D. Bucchini,et al. Tissue-specific expression of the rat insulin 1 gene in vivo requires both the enhancer and promoter regions. , 1995, Differentiation; research in biological diversity.
[54] J. Nielsen,et al. Rat insulinoma cells express both a 115-kDa growth hormone receptor and a 95-kDa prolactin receptor structurally related to the hepatic receptors. , 1990, The Journal of biological chemistry.
[55] C. J. Hedeskov,et al. Phorbol-ester-induced down-regulation of protein kinase C in mouse pancreatic islets. Potentiation of phase 1 and inhibition of phase 2 of glucose-induced insulin secretion. , 1990, The Biochemical journal.
[56] V. Bonnevie-Nielsen. Experimental diets affect pancreatic insulin and glucagon differently in male and female mice. , 1980, Metabolism: clinical and experimental.
[57] A. Rossini,et al. Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. , 1976, Science.